14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $2.95 Wednesday, 24th Apr 2024 CLLS stock ended at $2.50. This is 4.57% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.63% from a day low at $2.48 to a day high of $2.57.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Sep 24, 2020 $18.43 $18.43 $17.21 $17.35 190 485
Sep 23, 2020 $19.41 $19.43 $18.67 $18.79 162 697
Sep 22, 2020 $19.46 $19.46 $18.42 $19.10 326 571
Sep 21, 2020 $20.20 $20.27 $19.29 $19.42 98 806
Sep 18, 2020 $20.29 $20.99 $20.24 $20.84 155 196
Sep 17, 2020 $20.25 $20.48 $20.02 $20.35 111 982
Sep 16, 2020 $20.10 $20.50 $20.00 $20.27 217 905
Sep 15, 2020 $19.11 $20.20 $19.11 $20.18 200 689
Sep 14, 2020 $17.72 $19.13 $17.72 $19.11 232 969
Sep 11, 2020 $17.14 $17.62 $17.14 $17.45 119 482
Sep 10, 2020 $16.90 $17.66 $16.90 $17.16 174 673
Sep 09, 2020 $16.27 $16.90 $16.27 $16.75 103 153
Sep 08, 2020 $16.11 $16.51 $15.96 $15.96 142 436
Sep 04, 2020 $16.93 $17.05 $15.86 $16.30 225 538
Sep 03, 2020 $18.16 $18.25 $16.83 $17.00 187 212
Sep 02, 2020 $18.00 $18.45 $17.91 $18.40 122 403
Sep 01, 2020 $18.53 $18.63 $18.15 $18.44 65 867
Aug 31, 2020 $18.04 $18.61 $17.92 $18.45 158 775
Aug 28, 2020 $18.26 $18.33 $17.80 $18.16 150 047
Aug 27, 2020 $18.70 $18.70 $17.72 $17.93 98 351
Aug 26, 2020 $18.50 $18.69 $18.13 $18.46 106 300
Aug 25, 2020 $18.25 $18.53 $18.05 $18.36 103 782
Aug 24, 2020 $18.72 $18.82 $18.10 $18.34 108 341
Aug 21, 2020 $18.08 $18.54 $17.90 $18.29 130 271
Aug 20, 2020 $18.50 $18.73 $18.06 $18.52 166 020
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT